Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Evaluating blood flow in pancreatic remnants after surgery using fluorescence

Official title: Indocyanine Green Fluorescence in Evaluation of Post-resection Pancreatic Remnant Perfusion After Pancreaticoduodenectomy

Run by Charles University, Czech Republic · NCT06198400 · Data updated 2026-11-12

This study is testing if a special dye can help doctors see blood flow in the remaining part of the pancreas after surgery to predict the risk of complications like pancreatic fistulas in patients.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorCharles University, Czech Republic
Academic / other
Locations1 site (Prague, Czech Republic)
StatusRecruiting
StartedMay 1, 2024
Main results expectedJanuary 1, 2027
Study endsJuly 1, 2027
Registry record updatedAugust 21, 2024
Trial IDNCT06198400 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients scheduled for open pancreaticoduodenectomy during the study period.

Probably not a fit

Patients with allergies to indocyanine green or those undergoing mini-invasive procedures will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to assess the blood flow in the pancreatic remnant following pancreaticoduodenectomy by utilizing indocyanine green fluorescence. The research will involve consecutive patients undergoing this surgical procedure from May 2024 to December 2026. By evaluating the vascular supply of the pancreatic remnant, the study seeks to determine if this method can predict the risk of developing postoperative pancreatic fistulas. Patients will be categorized based on the adequacy of their vascular supply, and the incidence of complications will be compared between groups.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the incidence of pancreatic fistulas after surgery, improving patient outcomes.

How similar studies have gone: While the use of indocyanine green fluorescence for perfusion assessment is gaining traction, this specific application in pancreatic surgery is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All consecutive patients undergoing open pancreaticoduodenectomy at our department in the selected period

Exclusion Criteria:

* Allergy to indocyanine green
* Refusal by the patient
* Mini-invasive procedure.

Where it's running

  • Department of Surgery, Second Faculty of Medicine of Charles University and Military University Hospital Prague, Czech Republic
    Prague, Czech Republic, Czechia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.